Advertisement
Loading...

Chugai Pharmaceutical Co., Ltd.

CHGCYPNK
Healthcare
Drug Manufacturers - General
$25.10
$0.18(0.73%)
U.S. Market is Open • 15:34

Chugai Pharmaceutical Co., Ltd. (CHGCY) Stock Overview

Explore Chugai Pharmaceutical Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap82.1B
P/E Ratio27.49
EPS (TTM)$0.84
ROE0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$28.19
3 Months$26.85
1 Year Target$32.14

CHGCY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Chugai Pharmaceutical Co., Ltd. (CHGCY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.00, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $32.14.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 27.49 and a market capitalization of 82.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.04%
5-Day Change
-2.69%
1-Month Change
-6.56%
3-Month Change
-18.93%
6-Month Change
-5.32%
Year-to-Date (YTD) Change
-5.10%
1-Year Change
-5.71%
3-Year Change
91.03%
5-Year Change
31.14%
All-Time (Max) Change
717.38%

Contact Information

81 3 3281 6611
Nihonbashi Mitsui Tower, Tokyo, NaN, 103-8324

Company Facts

5,026 Employees
IPO DateAug 3, 2012
CountryJP
Actively Trading

Frequently Asked Questions